Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Daigle

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Genes, Brain, and Behavior|June 23, 2015
COMT polymorphism modulates the resting-state EEG alpha oscillatory response to acute nicotine in male non-smokersH Bowers, D Smith, S de la Salle, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2025
Spectrum of cefepime-taniborbactam coverage against 190 β-lactamases defined in engineered isogenic <i>Escherichia coli</i> strainsTsuyoshi Uehara, Cassandra L Chatwin, Brittany Miller, et al.
Journal of Environmental Management|May 27, 2021
Exceptions and exemptions under the ballast water management convention - Sustainable alternatives for ballast water management?Okko Outinen, Sarah A Bailey, Katja Broeg, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2022
<i>In Vitro</i> Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) ProgramJames A Karlowsky, Meredith A Hackel, Mark G Wise, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415Charles R Dean, Shubha Narayan, Denis M Daigle, et al.
Peerj|February 15, 2021
Aichi Target 18 beyond 2020: mainstreaming Traditional Biodiversity Knowledge in the conservation and sustainable use of marine and coastal ecosystemsPaola Fajardo, David Beauchesne, Alberto Carbajal-López, et al.
BMC Geriatrics|April 27, 2023
Sleep movements and respiratory coupling as a biobehavioral metric for early Alzheimer's disease in independently dwelling adultsSomayeh Khosroazad, Christopher F Gilbert, Jessica B Aronis, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2007
Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy numberCharles R Dean, Shubha Narayan, Joel Richards, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2021
Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of <i>Enterobacterales</i> Expressing Extended-Spectrum β-Lactamases and Serine CarbapenemasesCassandra L Chatwin, Jodie C Hamrick, Robert E L Trout, et al.
Journal of Medicinal Chemistry|November 26, 2019
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial InfectionsBin Liu, Robert E Lee Trout, Guo-Hua Chu, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Genes, Brain, and Behavior|June 23, 2015
COMT polymorphism modulates the resting-state EEG alpha oscillatory response to acute nicotine in male non-smokersH Bowers, D Smith, S de la Salle, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2025
Spectrum of cefepime-taniborbactam coverage against 190 β-lactamases defined in engineered isogenic <i>Escherichia coli</i> strainsTsuyoshi Uehara, Cassandra L Chatwin, Brittany Miller, et al.
Journal of Environmental Management|May 27, 2021
Exceptions and exemptions under the ballast water management convention - Sustainable alternatives for ballast water management?Okko Outinen, Sarah A Bailey, Katja Broeg, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2022
<i>In Vitro</i> Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) ProgramJames A Karlowsky, Meredith A Hackel, Mark G Wise, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415Charles R Dean, Shubha Narayan, Denis M Daigle, et al.
Peerj|February 15, 2021
Aichi Target 18 beyond 2020: mainstreaming Traditional Biodiversity Knowledge in the conservation and sustainable use of marine and coastal ecosystemsPaola Fajardo, David Beauchesne, Alberto Carbajal-López, et al.
BMC Geriatrics|April 27, 2023
Sleep movements and respiratory coupling as a biobehavioral metric for early Alzheimer's disease in independently dwelling adultsSomayeh Khosroazad, Christopher F Gilbert, Jessica B Aronis, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2007
Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy numberCharles R Dean, Shubha Narayan, Joel Richards, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2021
Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of <i>Enterobacterales</i> Expressing Extended-Spectrum β-Lactamases and Serine CarbapenemasesCassandra L Chatwin, Jodie C Hamrick, Robert E L Trout, et al.
Journal of Medicinal Chemistry|November 26, 2019
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial InfectionsBin Liu, Robert E Lee Trout, Guo-Hua Chu, et al.
Pageof 7